Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN117820257A details chiral hydrogenation for high-purity pinaverium bromide intermediate. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN103665109B reveals liquid phase synthesis for OGP pentapeptide. Offers cost reduction and scalability for pharmaceutical manufacturing supply chains.
Discover advanced polymer reverse-phase purification for Carbetocin. Achieve >99.5% purity and remove toxic D-Cys impurities efficiently for pharmaceutical manufacturing.
Patent CN110724125A reveals a mild copper-catalyzed route for 3-(7-hydroxy-1-oxoisoindole-2-yl)piperidine-2,6-diketone, offering superior stability and cost reduction in API manufacturing.
Novel patent CN104557561B offers safe high-yield route for pramiracetam intermediate ensuring cost reduction and supply stability for global buyers.
Patent CN101631872B reveals a novel process for beta-lactam compounds eliminating solid isolation. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN113896655A reveals a telescoped toluene-based route for Vonoprazan intermediate, offering >99.5% purity and scalable manufacturing for global supply chains.
Novel cyanoacetic acid route for Ramelteon intermediate. High yield, low cost, scalable process for API manufacturing.
Novel industrial method for Perindopril using accessible enamine precursors. Reduces synthetic steps, improves yield, and ensures high purity for API manufacturing.
Novel dutasteride synthesis using sodium perborate avoids toxic DDQ. High purity, scalable process for reliable pharmaceutical intermediate supplier.
Novel D-ribose route for 1-acetoxy-2,3,5-tribenzoyloxy-1-beta-D-ribofuranose. High yield, scalable process for API manufacturing.
Patent CN121202870A discloses a high-yield synthesis route for 5-isopropyl-non-nefarnesone impurity standards, offering significant supply chain stability and cost optimization for pharmaceutical manufacturers.
Patent CN114436930A reveals water-based synthesis for Boc-L-hydroxyproline. Achieves 99.9% purity, eliminates organic solvents, ensures supply chain stability.
Patent CN109678886B reveals a high-yield Boc-protection route for tazobactam intermediates, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis of 5-trifluoromethylpyrimidine derivatives via Buchwald-Hartwig coupling. High purity intermediates for anti-cancer drug development with scalable processes.
Patent CN107879955B details a high-purity glyburide synthesis using crown ether catalysis, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN118791551B details high-purity semaglutide dipeptide fragment synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates globally.
Advanced synthesis of cefpirome intermediate via novel silylation and iodination. Reduces waste, recovers iodine, and ensures high purity for pharmaceutical supply chains.
Novel nickel-catalyzed hydrogenation and lipase resolution method for high-purity 1-acenaphthenol. Enhances safety and yield for global pharmaceutical supply chains effectively.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.